Thailand Medical News - For All The Latest Breaking Medical News, Health News, Research News, COVID-19 News, Outbreak News, Dengue News, Glaucoma News, Diabetes News, Herb News, Phytochemical News, Heart And Cardiology News, Epigenetic News, Cancer News,

BREAKING NEWS
Source: COVID-19 And PPIs  Aug 16, 2021  2 years, 8 months, 3 days, 4 hours, 25 minutes ago

U.S. Study Shows That Users Of Proton Pump Inhibitors or PPIs Have Higher Mortality Risk When Infected With COVID-19

U.S. Study Shows That Users Of Proton Pump Inhibitors or PPIs Have Higher Mortality Risk When Infected With COVID-19
Source: COVID-19 And PPIs  Aug 16, 2021  2 years, 8 months, 3 days, 4 hours, 25 minutes ago
A new study by American researchers from multi-institutions led by the University of Arkansas for Medical Sciences and also involved University of Mississippi Medical Center, University of Louisville School of Dentistry University of Florida, Brigham and Women's Hospital-Boston, Boston Children's Hospital and University at Buffalo among many others, has found that users of PPIs or proton pump inhibitors have a higher mortality risk when they are infected with the SARS-CoV-2 coronavirus and develop the COVID-19 disease.

Proton pump inhibitors (PPIs) are a class of drugs used to treat GERD, peptic ulcers, and H. pylori. Examples of PPIs include Prilosec, Prevacid, Aciphex, Pantoprazole, Lansoprazole, ‎Esomeprazole (Nexium), Omeprazole (Miracid) etc.
 
The study findings were published in the peer reviewed American Journal of Gastroenterology. https://journals.lww.com/ajg/Fullte